Literature DB >> 26746838

Unusual cause of flare in antineutrophil cytoplasmic antibody-associated vasculitis.

James Robert William Glanville1, Henry Penn1.   

Abstract

A 53-year-old woman attended for a routine outpatient appointment for follow-up of antineutrophil cytoplasmic antibody-positive vasculitis. Her disease had relapsed despite appropriate medical management with mycophenolate mofetil (MMF), as evidenced by rising acute phase response and antimyeloperoxidase titre with ongoing symptoms. On further questioning, she had been taking oral charcoal as part of a detoxification diet, which we postulate was causing significantly impaired MMF absorption. This case report summarises the presentation and highlights the importance of a thorough drug history, and should prompt the reader to keep an open mind with regard to drug interactions and treatment regimen adherence when treatment is, unexpectedly, seemingly failing. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26746838      PMCID: PMC4716376          DOI: 10.1136/bcr-2015-213687

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

Review 1.  ANCA-positive vasculitis.

Authors:  Lavanya Kamesh; Lorraine Harper; Caroline O S Savage
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121

Review 2.  The role of biologics in treatment of ANCA-associated vasculitis.

Authors:  Chethana Dharmapalaiah; Richard A Watts
Journal:  Mod Rheumatol       Date:  2011-10-29       Impact factor: 3.023

3.  Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial.

Authors:  Thomas F Hiemstra; Michael Walsh; Alfred Mahr; Caroline O Savage; Kirsten de Groot; Lorraine Harper; Thomas Hauser; Irmgard Neumann; Vladimir Tesar; Karl-Martin Wissing; Christian Pagnoux; Wilhelm Schmitt; David R W Jayne
Journal:  JAMA       Date:  2010-11-08       Impact factor: 56.272

4.  Management of ANCA-associated vasculitis: Current trends and future prospects.

Authors:  Sally Hamour; Alan D Salama; Charles D Pusey
Journal:  Ther Clin Risk Manag       Date:  2010-06-24       Impact factor: 2.423

Review 5.  Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses.

Authors:  P J Neuvonen; K T Olkkola
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jan-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.